By phosphorylating glycogen synthase kinase-3 beta (GSK-3b), NF-kB, and ERK1/2, the CXCR6-CXCL16 axis promotes docetaxel resistance in PCa patients [235]. Here, CXCR6 is linked to posterior cortical atrophy.